Excel Industries Ltd
Excel Industries is engaged in manufacturing and selling of Chemicals, Pharma intermediates and Environmental products. [1]
- Market Cap ₹ 1,882 Cr.
- Current Price ₹ 1,497
- High / Low ₹ 1,650 / 699
- Stock P/E 44.6
- Book Value ₹ 1,135
- Dividend Yield 0.37 %
- ROCE 1.57 %
- ROE 1.00 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 25.3%
Cons
- The company has delivered a poor sales growth of 0.03% over past five years.
- Company has a low return on equity of 7.21% over last 3 years.
- Earnings include an other income of Rs.35.0 Cr.
- Debtor days have increased from 65.3 to 81.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
384 | 416 | 482 | 448 | 462 | 599 | 825 | 702 | 749 | 1,178 | 1,090 | 826 | 877 | |
344 | 376 | 409 | 385 | 419 | 474 | 574 | 571 | 628 | 946 | 961 | 801 | 822 | |
Operating Profit | 40 | 40 | 72 | 63 | 44 | 125 | 250 | 131 | 122 | 232 | 129 | 25 | 55 |
OPM % | 10% | 10% | 15% | 14% | 9% | 21% | 30% | 19% | 16% | 20% | 12% | 3% | 6% |
4 | 5 | 7 | 3 | 9 | 4 | 5 | 10 | 9 | 15 | 12 | 32 | 35 | |
Interest | 12 | 12 | 14 | 13 | 11 | 7 | 3 | 4 | 3 | 3 | 3 | 3 | 2 |
Depreciation | 10 | 11 | 15 | 15 | 14 | 15 | 18 | 23 | 27 | 31 | 31 | 31 | 32 |
Profit before tax | 22 | 21 | 51 | 38 | 27 | 107 | 234 | 115 | 101 | 213 | 106 | 23 | 56 |
Tax % | 32% | 15% | 19% | 31% | 26% | 31% | 34% | 16% | 29% | 24% | 24% | 25% | |
15 | 18 | 41 | 26 | 20 | 74 | 153 | 96 | 71 | 161 | 80 | 17 | 42 | |
EPS in Rs | 13.69 | 16.50 | 34.59 | 20.18 | 15.93 | 58.78 | 122.07 | 76.42 | 56.55 | 128.23 | 63.59 | 13.53 | 33.54 |
Dividend Payout % | 22% | 23% | 20% | 22% | 38% | 21% | 15% | 13% | 20% | 18% | 18% | 41% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 0% |
3 Years: | 3% |
TTM: | -10% |
Compounded Profit Growth | |
---|---|
10 Years: | -3% |
5 Years: | -39% |
3 Years: | -43% |
TTM: | -14% |
Stock Price CAGR | |
---|---|
10 Years: | 18% |
5 Years: | 12% |
3 Years: | 12% |
1 Year: | 75% |
Return on Equity | |
---|---|
10 Years: | 11% |
5 Years: | 8% |
3 Years: | 7% |
Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 130 | 143 | 179 | 204 | 404 | 526 | 693 | 695 | 845 | 1,143 | 1,235 | 1,421 |
73 | 102 | 95 | 89 | 68 | 10 | 7 | 24 | 9 | 7 | 3 | 2 | |
95 | 100 | 108 | 121 | 141 | 186 | 209 | 212 | 251 | 330 | 248 | 367 | |
Total Liabilities | 303 | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 |
121 | 128 | 158 | 164 | 183 | 203 | 238 | 376 | 389 | 427 | 428 | 428 | |
CWIP | 5 | 20 | 3 | 3 | 8 | 23 | 12 | 10 | 17 | 21 | 19 | 19 |
Investments | 22 | 22 | 23 | 27 | 211 | 282 | 394 | 264 | 365 | 547 | 625 | 962 |
156 | 181 | 204 | 227 | 216 | 220 | 272 | 287 | 340 | 492 | 421 | 388 | |
Total Assets | 303 | 352 | 387 | 421 | 619 | 728 | 916 | 937 | 1,111 | 1,487 | 1,493 | 1,795 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
27 | 13 | 44 | 46 | 31 | 119 | 135 | 110 | 91 | 109 | 125 | 72 | |
-25 | -32 | -27 | -27 | 16 | -45 | -111 | -61 | -53 | -104 | -118 | -51 | |
-4 | 20 | -23 | -17 | -48 | -73 | -24 | -31 | -17 | -17 | -35 | -17 | |
Net Cash Flow | -2 | 1 | -6 | 1 | -1 | 1 | -0 | 17 | 21 | -12 | -27 | 4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 84 | 89 | 80 | 103 | 95 | 76 | 70 | 78 | 84 | 62 | 52 | 82 |
Inventory Days | 77 | 74 | 103 | 99 | 86 | 79 | 75 | 90 | 71 | 103 | 78 | 80 |
Days Payable | 91 | 81 | 84 | 112 | 98 | 123 | 108 | 122 | 126 | 112 | 64 | 139 |
Cash Conversion Cycle | 71 | 82 | 99 | 90 | 83 | 32 | 36 | 46 | 29 | 52 | 67 | 23 |
Working Capital Days | 65 | 77 | 74 | 82 | 82 | 54 | 60 | 61 | 54 | 62 | 61 | 57 |
ROCE % | 17% | 15% | 24% | 18% | 10% | 22% | 38% | 17% | 13% | 21% | 9% | 2% |
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10h
- Closure of Trading Window 30 Sep
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 Sep
-
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
24 Sep - Intimation of loss of original share certificates.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 23 Sep
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Market Position
The company is the No. 1 Producer of DETC (Diethylthiophosphoryl Chloride) and one of the Top 5 Producers of Phosphonates in the world. [1]